Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mark Hogarth

Showing results (1-10 of 121) with videos related to

Pageof 13
Sort By:
Current Opinion in Immunology|November 5, 2002
Fc receptors are major mediators of antibody based inflammation in autoimmunityP Mark Hogarth
Immunological Reviews|October 27, 2015
Fc Receptors: IntroductionP Mark Hogarth
Tissue Antigens|July 27, 2006
IgA receptors in health and diseaseBruce D Wines, P Mark Hogarth
Nature Reviews. Drug Discovery|March 31, 2012
Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyondP Mark Hogarth, Geoffrey A Pietersz
Advances in Experimental Medicine and Biology|December 11, 2008
Fc receptorsMaree S Powell, P Mark Hogarth
Current Topics in Microbiology and Immunology|August 14, 2014
The FcγR of humans and non-human primates and their interaction with IgG: implications for induction of inflammation, resistance to infection and the use of therapeutic monoclonal antibodiesP Mark Hogarth, Jessica C Anania, Bruce D Wines
Immunology Letters|February 11, 2014
ZSWIM1: a novel biomarker in T helper cell differentiationK Kerry Ko, Maree S Powell, P Mark Hogarth
Immunology and Cell Biology|September 13, 2003
The role of FcgammaRIIa as an inflammatory mediator in rheumatoid arthritis and systemic lupus erythematosusCaroline Tan Sardjono, Patricia L Mottram, P Mark Hogarth
Springer Seminars in Immunopathology|November 9, 2006
FcgammaRII and multi-system autoimmune diseaseNicholas C van de Velde, Patricia L Mottram, P Mark Hogarth
The Journal of Biological Chemistry|November 19, 2005
A competitive mechanism for staphylococcal toxin SSL7 inhibiting the leukocyte IgA receptor, Fc alphaRI, is revealed by SSL7 binding at the C alpha2/C alpha3 interface of IgABruce D Wines, Natasha Willoughby, John D Fraser, et al.
Pageof 13

Showing results (1-10 of 121) with videos related to

Sort By:
Pageof 13
Current Opinion in Immunology|November 5, 2002
Fc receptors are major mediators of antibody based inflammation in autoimmunityP Mark Hogarth
Immunological Reviews|October 27, 2015
Fc Receptors: IntroductionP Mark Hogarth
Tissue Antigens|July 27, 2006
IgA receptors in health and diseaseBruce D Wines, P Mark Hogarth
Nature Reviews. Drug Discovery|March 31, 2012
Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyondP Mark Hogarth, Geoffrey A Pietersz
Advances in Experimental Medicine and Biology|December 11, 2008
Fc receptorsMaree S Powell, P Mark Hogarth
Current Topics in Microbiology and Immunology|August 14, 2014
The FcγR of humans and non-human primates and their interaction with IgG: implications for induction of inflammation, resistance to infection and the use of therapeutic monoclonal antibodiesP Mark Hogarth, Jessica C Anania, Bruce D Wines
Immunology Letters|February 11, 2014
ZSWIM1: a novel biomarker in T helper cell differentiationK Kerry Ko, Maree S Powell, P Mark Hogarth
Immunology and Cell Biology|September 13, 2003
The role of FcgammaRIIa as an inflammatory mediator in rheumatoid arthritis and systemic lupus erythematosusCaroline Tan Sardjono, Patricia L Mottram, P Mark Hogarth
Springer Seminars in Immunopathology|November 9, 2006
FcgammaRII and multi-system autoimmune diseaseNicholas C van de Velde, Patricia L Mottram, P Mark Hogarth
The Journal of Biological Chemistry|November 19, 2005
A competitive mechanism for staphylococcal toxin SSL7 inhibiting the leukocyte IgA receptor, Fc alphaRI, is revealed by SSL7 binding at the C alpha2/C alpha3 interface of IgABruce D Wines, Natasha Willoughby, John D Fraser, et al.
Pageof 13